Résumés
Résumé
Le jeu pathologique consiste en une pratique inadaptée, persistante et répétée du jeu qui a des répercussions majeures sur les individus touchés, leur famille et la société (APA, 2003). Plusieurs facteurs de risque de nature biologique, psychologique et sociale ont été soulevés comme pouvant contribuer au jeu pathologique. Une nouvelle population à risque a récemment été découverte : les patients atteints de la Maladie de Parkinson. Le développement d’un jeu pathologique chez ces patients serait principalement relié à une médication associée au traitement de la Maladie de Parkinson, les agonistes dopaminergiques. Bien qu’une recrudescence d’études neurologiques qui s’intéressent à ce phénomène ait été notée, peu d’intervenants semblent être au courant de cette problématique et peu de recherches ont été réalisées afin d’étudier les aspects psychologiques de cette problématique.
Abstract
Pathological gambling implies an inadequate, persistent and chronic practice of gambling which has major impact on affected individuals, their families and the society (APA, 2003). Many risk factors of social, psychological and biological nature contribute to the development of pathological gambling. New populations have been found to be at risk to develop pathological gambling : patients who suffer of Parkinson Disease’s. Development of pathological gambling in those patients would mainly be related to the medication used to treat Parkinson Disease’s, dopaminergic agonist. Numerous neurological studies have been conducted on the subject since recent years, but few psychologists know this problem and almost no studies have been made to understand the psychological aspect of this problem.
Parties annexes
Bibliographie
- Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., Santangelo, G., Foltynie, T., Janvin, C., Larsen, J. P., Barker, R. A., Emre, M., 2010, Mild cognitive impairment in Parkinson disease : A multicenter pooled analysis, Neurology, 75, 1062-1069.
- American Psychiatric Association, 2003, DSM-IV-TR, Manuel diagnostique et statistique des troubles mentaux, texte révisé, Masson, Paris.
- Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pelissolo, A., Moro, E., Lhommee, E., Lang, A. E., Agid, Y., Benabid, A. L., Pollak, P., Mallet, L., Krack, P., 2006, Pathological gambling in Parkinson’s disease improves on chronic subthalamic nucleus stimulation, Movement Disorders, 21, no 11, 1941-1946.
- Avanzi, M., Uber, E., Bonfà, F., 2004, Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease, Neurological Sciences, 25, no 2, 98-101.
- Chevalier, S., Hamel, D., Ladouceur, R., Jacques, C., Allard, D., Sévigny, S., 2004, Comportements de jeu et jeu pathologique selon le type de jeu au Québec en 2002, Institut national de santé publique du Québec, Montréal.
- Cilia, R., Siri, C., Marrota, G., Isaias, I. U., De Gaspari, D., Canesi, M., Pezzoli, G. Antonini, A., 2008, Functional abnormalities underlying pathological gambling in Parkinson disease, Archives of Neurology, 65, no 12, 1604-1611.
- Cummings, J. L., 1992, Depression and Parkinson’s disease : A review, American Journal of Psychiatry, 149, no 4, 443-454.
- Driver-Dunckley, E. D., Noble, B. N., Hentz, J. G., Evidente, V. G. H., Caviness, J. N., Parish, J., Krahn, L., Adler, C. H., 2007, Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome, Clinical Neuropharmacology, 30, no 5, 249-255.
- Driver-Dunckley, E. D., Samanta, J., Stacy, M., 2003, Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease, Neurology, 61, no 3, 422-423.
- Factor, S. A., Molho, E. S., Podskalny, G. D., Brown, D., 1995, Parkinson’s disease : drug-induced psychiatric states, Advances in Neurology, 65, 115-138.
- Foley, S. R., Arthur, K., Kelly, B. D., 2006, Psychiatric sequelae of Parkinson disease : A case report, European Psychiatry, 21, no 3, 211-213.
- Gallagher, D. A., O’Sullivan, S.S., Evans, A. H., Lees, A. J., Schrag, A., 2007, Pathological gambling in Parkison’s disease, risk factors and difference from dopamine dysregulation : An analysis of published case series, Movement Disorders, 22, no 12, 1757-1763.
- Gerstein, D. R., Volberg, R. A., Toce, M. T., 1999, Gambling Impact and Behaviour Study : Report to the National Gambling Impact Study Commission, University of Chicago Press, Chigago, IL.
- Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., Peretz, C., 2007, New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with parkinson’s disease : The role of dopamine agonist treatment and age at motor symptoms onset, Journal of Psychopharmacology, 21, no 5, 501-506.
- Grosset, K.A., Macphee, G., Pal, G., Stewart, D., Watt, A., Davie, J., Grosset, D. G., 2006, Problematic gambling on dopamine agonist : not such a rarity, Movement Disorders, 21, no 12, 2206-2208.
- Gurevich, E.V., Joyce, J. N., 1999, Distribution of dopamine D3 receptor expressing neurons in the human forebrain : comparison with D2 receptor expressing neurons, Neuropsychopharmacology, 20, no 1, 60-80.
- Halliday, G.M., McCann, H., 2010, The progression of pathology in Parkinson’s disease, Annals of the New York Academy of Science, 1184, no 1, 188-195.
- Jankovic, J., Stacy, M., 1999, Movement Disorders in Goetz, C. G., Pappert, E. J., ed., Textbook of Clinical Neurology, Saunders, Philadelphia.
- Johansson, A., Grant, J. E., Kim, S. W., Odlaug, B. L., Gotestam, K. G., 2009, Risk factors for problematic gambling : a critical literature review, Journal of Gambling Studies, 25, no 1, 67-92.
- Kairouz, S., Nadeau, L., 2011, Enquête ENHJEU — Portrait du jeu au Québec : Prévalence, incidence et trajectoires sur quatre ans, Fonds de recherche sur la société et la culture, Montréal, Extrait du site web de l’équipe de recherche le 23 août 2011 : http://socianth.concordia.ca/pages/JeuxAuHasard2009.php
- Lader, M., 2008, Antiparkinsonian medication and pathological gambling, CNS Drugs, 22, no 5, 407-416.
- Ladouceur, R., Sylvain, C., Jacques, C., Boutin, C., Lachance, S., Doucet, C., Leblond, J., Jacques, C., 2001, Cognitive treatment of pathological gambling, Journal of Nervous and Mental Disease, 189, no 11, 766-773.
- Ladouceur, R., Sylvain, C., Sévigny, S., Poirier, L., Brisson, L., Dias, C., Dufour, C., Pilote, P., 2006, Pathological Gamblers : Inpatients’ versus Outpatients’ Characteristics, Journal of Gambling Studies, 22, no 4, 443-450.
- Lorenz, V. C., Yaffee, R. A., 1986, Psychosomatic, emotional and marital difficulties as reported by the gambler, Journal of Gambling Behavior, 2, no 1, 40-49.
- Koroll, M., Tanner, C. M., 2005, Epidemiology of Parkinson’s disease : an overview in Ebadi, M., F.R. Pfeiffer., Ed, Parkinson’s disease, CRC Press : Boca Raton, FL, 39-50.
- McKeon, A., Josephs, K. A., Klos, K. J., Hecksel, K., Bower, J. H., Bostwick, J. M., Ahlskog, J., 2007, Unusual compulsive behaviors primarily related to dopamine agonist therapy in parkinson’s disease and multiple system atrophy, Parkinsonism & Related Disorders, 13, no 8, 516-519.
- Morano, A., Jimenez-Jimenez, F. J., Molina, J. A., Antolin, M. A., 1994, Risk-factors for Parkinson’s disease : case-control study in the province of Caceres, Spain, Acta Neurologica Scandinavica, 89, no 3, 164-170.
- Muelleman, R. L., Den Otter, T., Wadman, M. C., Tran, T.P., Anderson, J., 2002, Problem gambling in the partner of the emergency department patient as a risk factor for intimate partner violence, The Journal of Emergency Medicine, 23, no 3, 307-312.
- National Council on Welfare, 1996, Gambling in Canada : A Report, Minister of Human Resources and Social Development, Ottawa.
- Pietrzak, R. H., Petry, N. M., 2006, Severity of gambling problems and psychosocial functioning in older adults, Journal of Geriatric Psychiatry and Neurology, 19, no 106, 106-113.
- Pillon, B., Czernecki, V., Dubois, B., 2003, Dopamine and cognitive function, Current Opinion in Neurology, 16, s17-s22.
- Quickfall, J., Suchowersky, O., 2007, Pathological gambling associated with dopamine agonist use in restless legs syndrome, Parkinsonism & Related Disorders, 13, no 8, 535-536.
- Reuters, J., Raedler, T., Rose, M., Hand, I., Glascher, J., Buchel, C., 2005, Pathological gambling is linked to reduced activation of the mesolimbic reward system, Nature Neuroscience, 8, no 2, 147-148.
- Shallice, T., 1988, From Neuropsychology to Mental Structure, Cambridge University Press, Cambridge.
- Shizgal, P., Arvanitogiannis, A., 2003, Neuroscience : gambling on dopamine (comment), Science, 299, no 5614, 1856-1858.
- Singh A., Kandimala, G., Dewey Jr, R. B., O’Suilleabhain, P., 2007, Risk factors for pathologic gambling and other compulsions among Parkinson’s disease patients taking dopamine agonists, Journal of Clinical Neuroscience, 14, no 12, 1178 – 1181.
- Smeding, H. M., Goudriaan, A. E., Foncke, E. M., Shuurman, P. R., Speelman, J. D., Schmand, B., 2007, Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson’s disease, Journal of Neurology, Neurosurgery and Psychiatry, 78, no 5, 517-519.
- Société Parkinson Canada, 2012, Un règlement a été approuvé relativement au recours collectif concernant Permax, Récupéré du site web de la Société Parkinson du Canada le 24 août 2011 : http://www.parkinson.ca/site/c.jpIMKWOBJoG/b.7697597/k.C1D1/Un_r232glement_a_233t233_approuv233_relativement_au_recours_collectif_concernant_Permax.htm
- Société Parkinson Québec, 2011, Chapitre 1 : La maladie et ses traitements, Récupéré du site web de la Société Parkinson du Québec le 24 août 2011 : http://www.parkinsonquebec.ca/__fr/la-maladie-de-parkinson/documentation.php
- Taylor, A. E., Saint-Cyr, J., 1995, The neuropsychology of Parkinson’s disease, Brain and Cognition, 28, no 3, 281-296.
- Voon, V., 2004, Repetition, repetition, and repetition : compulsive and punding behaviours in Parkinson’s Disease, Movement Disorder, 19, no 4, 367-370.
- Voon, V., Hassan, K., Zurowski, M., Duff-Canning, S., de Souza, M., Fox, S. H., Lang, A. E., Miyasaki, J., 2006, Prospective prevalence of pathologic gambling and medication association in parkinson disease, Neurology, 66, no 11, 1750-1752.
- Voon, V., Thomsen, T., Miyasaki, J. M., de Souza, M., Shafro, A., Fox, S. H., Duff-Canning, S., Lang, A. E., Zurowski, M., 2007, Factors associated with dopaminergic drug-related pathological gambling in parkinson disease, Archives of Neurology, 64, no 2, 212-216.
- Voon, V., Fox, S. H., 2007, Medication-related impulse control and repetitive behaviours in Parkinson disease, Neurological Review, 64, no 8, 1089-1096.
- Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G. R., Lang, A. E., 2010, Impulse control disorders in Parkinson disorder : A cross-sectional study of 3090 patients, Archives of Neurology, 67, no 5, 589-595.
- Wint, D. P., Okun, M. S., Fernandez, H. H., 2004, Psychosis in parkinson’s disease, Journal of Geriatric Psychiatry and Neurology, 17, no 3, 127-136.